We at Colzyx believe that by developing WOUNDCOM, a bioactive wound dressing, we can address this emerging problem, contribute to a better quality of life and make a difference in the fight against multidrug-resistant bacteria. WOUNDCOM has a proven dual function of accelerating wound healing and having a pronounced effect on a wide range of bacterial infections, including multidrug-resistant bacteria. Hence, WOUNDCOM represents advanced wound care with specific tissue regeneration properties. We are making use of the human body's own wound healing and antibacterial processes. We have identified, isolated and further developed key molecules from the human innate immune system that are produced in the natural wound healing process. The addition of these molecules in the form of WOUNDCOM to a wound, has been shown to accelerate the natural wound healing process and synergistically kill bacteria that invade the wound. WOUNDCOM is presently being developed with the aim to be registered as a medical device and will be evaluated in clinical trials focusing on the healing of chronic wounds.
